IOVA · Iovance Biotherapeutics, Inc. · Debt
Market Cap
$3.93B
Shares
452.97M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
1425205
CUSIP
462260100
13F (30d)
176 filings
175 filers
Visit website
Investor relations